30
Dec

Back in the summer of 2013, Celgene lined up with a group of stalwarts to pump $33 million into the struggling regenerative medicine company Tengion, which had two programs in early-stage development. Today, the biotech powerhouse was listed as a creditor on an international roster of R&D groups and support companies that are getting stiffed in a Chapter 7 filing.

…read more

Source: Celgene joins an international list of creditors in Tengion’s Ch7 bankruptcy filing

    

0 No comments